Literature DB >> 14597514

Common forms of childhood exotropia.

Brian G Mohney1, Roland Keith Huffaker.   

Abstract

OBJECTIVE: To determine the most common forms of childhood exotropia.
DESIGN: Retrospective, consecutive, observational case series. PARTICIPANTS: All exotropic children (with >/=10 prism diopters) younger than 19 years from a predominantly rural Appalachian region evaluated from August 1, 1995 through July 31, 2001.
METHODS: Demographic and clinical data were collected on all patients. MAIN OUTCOME MEASURES: The relative proportion of the various forms of childhood exotropia.
RESULTS: Two hundred thirty-five consecutive children without prior surgical treatment were evaluated for exotropia. Of the 235 study children, the specific forms of exotropia diagnosed and numbers were as follows: intermittent exotropia, 112 (47.7%); exotropia associated with congenital or acquired abnormalities of the central nervous system (CNS), 50 (21.3%); convergence insufficiency, 27 (11.5%); sensory exotropia, 24 (10.2%); paralytic exotropia, 5 (2.1%); congenital exotropia, 4 (1.7%); neonatal exotropia that resolved after 4 months of age, 3 (1.3%), whereas the remaining 10 (4.3%) had an undetermined form of exodeviation.
CONCLUSIONS: Intermittent exotropia was the most common form of divergent strabismus in this population. Exotropia associated with an abnormal CNS, convergence insufficiency, and sensory exotropia were also relatively common, whereas the congenital, paralytic, and late-resolving neonatal forms were uncommon.

Entities:  

Mesh:

Year:  2003        PMID: 14597514     DOI: 10.1016/j.ophtha.2003.04.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  34 in total

1.  Strabismus surgery before versus after completion of amblyopia therapy in children.

Authors:  Sanita Korah; Swetha Philip; Smitha Jasper; Aileen Antonio-Santos; Andrew Braganza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-15

2.  Contrasting effects of strabismic amblyopia on metabolic activity in superficial and deep layers of striate cortex.

Authors:  Daniel L Adams; John R Economides; Jonathan C Horton
Journal:  J Neurophysiol       Date:  2015-03-25       Impact factor: 2.714

3.  Long-term outcomes of bilateral lateral rectus recession versus unilateral lateral rectus recession-medial rectus plication in children with basic type intermittent exotropia.

Authors:  Haeng-Jin Lee; Seong-Joon Kim; Young Suk Yu
Journal:  Eye (Lond)       Date:  2019-04-03       Impact factor: 3.775

4.  New tests of distance stereoacuity and their role in evaluating intermittent exotropia.

Authors:  Jonathan M Holmes; Eileen E Birch; David A Leske; Valeria L Fu; Brian G Mohney
Journal:  Ophthalmology       Date:  2007-01-22       Impact factor: 12.079

5.  Comitant horizontal strabismus: an Asian perspective.

Authors:  Audrey Chia; Lipika Roy; Linley Seenyen
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

6.  Variability of stereoacuity in intermittent exotropia.

Authors:  Sarah R Hatt; Brian G Mohney; David A Leske; Jonathan M Holmes
Journal:  Am J Ophthalmol       Date:  2008-01-16       Impact factor: 5.258

7.  Strabismus Incidence in a Danish Population-Based Cohort of Children.

Authors:  Tobias Torp-Pedersen; Heather A Boyd; Line Skotte; Birgitte Haargaard; Jan Wohlfahrt; Jonathan M Holmes; Mads Melbye
Journal:  JAMA Ophthalmol       Date:  2017-10-01       Impact factor: 7.389

8.  Clinical investigation of surgery for intermittent exotropia.

Authors:  Chong-qing Yang; Ye Shen; Yang-shun Gu; Wei Han
Journal:  J Zhejiang Univ Sci B       Date:  2008-06       Impact factor: 3.066

9.  Variability of control in intermittent exotropia.

Authors:  Sarah R Hatt; Brian G Mohney; David A Leske; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2007-07-16       Impact factor: 12.079

Review 10.  Interventions for intermittent exotropia.

Authors:  Sarah R Hatt; Lawrence Gnanaraj
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.